Related Experiment Video
Updated: Jul 22, 2026

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
Published on: July 31, 2012
A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell
L S Nielsen1, G M Kellerman, N Behrendt
1Finsen Laboratory, Rigshospitalet, Copenhagen, Denmark.
Abstract:
The iodinated Mr approximately equal to 15,000 amino-terminal fragment (ATF) of the urokinase-type plasminogen activator (u-PA) molecule bound specifically to the cell surface of all of seven cultured human tumor cell lines studied. Cross-linking of iodinated ATF to the cell surface using a bifunctional amino-reactive reagent followed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography revealed with the four cell lines studied the occurrence of a single band migrating with an Mr of 70,000-75,000, indicating complex formation with an Mr of 55,000-60,000 u-PA receptor protein (u-PA-R). In the human monocyte cell line U937 cultivated in the presence of phorbol ester, the amount of complex was strongly increased, and a fraction of the complex had a slower electrophoretic mobility. Comparison between autoradiograms of reduced and unreduced samples suggests that u-PA-R consists of one polypeptide chain. Two forms of u-PA-R, which differed with respect to affinity to concanavalin A, were identified. u-PA-R retained its ability to bind to ATF after cell lysis, and it was purified approximately 2,200-fold from biosynthetically labeled U937 cells by affinity chromatography with proenzyme u-PA coupled to Sepharose. The purified Mr 55,000-60,000 protein was specifically bound and cross-linked to u-PA, proenzyme u-PA, and ATF, but not to tissue-type plasminogen activator or other unrelated proteins.
Insights
The urokinase-type plasminogen activator receptor (u-PA-R) binds to the amino-terminal fragment (ATF) of urokinase-type plasminogen activator (u-PA). This study identifies and characterizes u-PA-R, a key protein in cell surface interactions.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Urokinase-type plasminogen activator (u-PA) plays a role in cell surface interactions.
- The u-PA receptor (u-PA-R) mediates these interactions.
- Understanding u-PA-R is crucial for studying cellular processes.
Purpose of the Study:
- To investigate the binding characteristics of the amino-terminal fragment (ATF) of u-PA.
- To identify and characterize the u-PA receptor (u-PA-R) on human tumor cell lines.
- To determine the molecular properties of u-PA-R.
Main Methods:
- Cell surface binding assays using iodinated ATF.
- Cross-linking of ATF to cell surface proteins.
- Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
- Affinity chromatography for protein purification.
Main Results:
- Iodinated ATF specifically bound to the cell surface of human tumor cell lines.
- A 55,000-60,000 Mr u-PA receptor protein (u-PA-R) was identified.
- u-PA-R consists of a single polypeptide chain and exhibits varying affinities for concanavalin A.
- Purified u-PA-R specifically bound u-PA, proenzyme u-PA, and ATF.
Conclusions:
- The u-PA receptor (u-PA-R) is a cell surface protein that binds the amino-terminal fragment (ATF) of urokinase-type plasminogen activator (u-PA).
- u-PA-R was purified and characterized, revealing its molecular structure and binding specificities.
- These findings contribute to the understanding of u-PA mediated cell signaling pathways.

